Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Carl Kihm

Podiatrist, Foot & Ankle Surgery Louisville, KY Doctor of Podiatric Medicine

NPI 1063771715 CMS profile 274935

3 Audubon Plaza Dr Ste 320, Louisville, KY 40217

Open in the dashboard

General payments

$89,224

360 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Carl Kihm of Louisville, KY is reported in the CMS Open Payments database as having received $89,224 across 360 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $64,269 95
2024 General $14,800 51
2023 General $1,979 59
2022 General $1,585 56
2021 General $1,286 42
2020 General $3,931 41
2019 General $1,374 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Carl Kihm
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Carl Kihm were reported at $64,269. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Carl Kihm Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $1,374 $389 $118–$1,406 $163
2020 $3,931 $191 $62–$691 $114
2021 $1,286 $329 $104–$1,341 $132
2022 $1,585 $419 $125–$1,611 $149
2023 $1,979 $377 $128–$1,164 $160
2024 $14,800 $394 $134–$1,168 $164
2025 $64,269 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bioventus LLC $45,254 98 payments
  2. Fusion Orthopedics USA, LLC $30,790 10 payments
  3. Stryker Corporation $2,768 40 payments
  4. Paragon 28, Inc. $2,764 5 payments
  5. Alpha Orthopedic Systems $1,269 9 payments
  6. Smith+Nephew, Inc. $1,147 85 payments
  7. Carbofix Orthopedics Inc $950 7 payments
  8. Integra LifeSciences Corporation $763 15 payments
  9. Paratek Pharmaceuticals, Inc. $470 20 payments
  10. Misonix Inc $418 24 payments
  11. Other $2,630 47 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $36,766 21 payments
  2. Consulting Fee $25,050 5 payments
  3. Travel and Lodging $12,677 41 payments
  4. Food and Beverage $10,468 286 payments
  5. Charitable Contribution $2,689 3 payments
  6. Education $1,574 4 payments
Products named General payments · program years 2019–2025
  1. EXOGEN ULTRASOUND BONE HEALING SYSTEM $45,005 89 payments
  2. LapiLock $11,100 3 payments
  3. MiniLock $2,700 1 payment
  4. STRAVIX $874 66 payments
  5. VARIAX $865 8 payments
  6. Integra Recon-Skin And Wound $622 12 payments
  7. Integra Recon-Skin And Wound $622 12 payments
  8. PRIMATRIX $622 12 payments
  9. Integra Recon-Skin And Wound $622 12 payments
  10. INTEGRA DERMAL REGENERATION TEMPLATE $622 12 payments
  11. Other $9,188 202 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

337

Median for Podiatry: 160

Drug cost

$4,403

Median for Podiatry: $2,368

Branded share of claims

22%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 70 $920
Ketoconazole Generic 36 $889
Meloxicam Generic 20 $694
Pregabalin Generic 22 $679
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 51 $288
Doxycycline Hyclate Generic 33 $244
Terbinafine Hcl Generic 26 $206
Diclofenac Sodium Generic 16 $130
Cephalexin Generic 19 $126
Ciprofloxacin Hcl Generic 21 $112

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 99 billing codes

Paid by Medicare

$273,668

Of which drugs: $160,221

Medicare patients

348

Average age 73

Services billed

1,832

204 women, 144 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 61%
Diabetes 51%
Ischemic heart disease 37%
Chronic kidney disease 30%
Depression 26%
Heart failure 24%
COPD 24%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 22 74 $55

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
NUZYRA
  • Paratek Pharmaceuticals, Inc. $37
$37 — —
DALVANCE
  • AbbVie, Inc. $24
$24 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

360 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record